Voloridge Investment Management, LLC Castle Biosciences Inc Transaction History

Voloridge Investment Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $1.11 Million - $1.69 Million	-49,185 Reduced 42.18%	67,432 $1.76 Million
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $1.87 Million - $5.36 Million	116,617 New	116,617 $2.56 Million
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $709,681 - $1.23 Million	-18,169 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $1.09 Million - $1.41 Million	18,169 New	18,169 $1.21 Million
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $2.06 Million - $3.15 Million	-41,070 Closed	0 $0

Q1 2021 May 17, 2021	BUY	$58.92 - $97.33 $335,372 - $554,002	5,692 Added 16.09%	41,070 $2.81 Million
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $331,578 - $555,545	7,605 Added 27.38%	35,378 $2.38 Million
Q3 2020 Nov 16, 2020	BUY	$38.47 - $52.03 $1.07 Million - $1.45 Million	27,773 New	27,773 $1.43 Million

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.